Kyle Guse
2019
In 2019, Kyle Guse earned a total compensation of $2.3M as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics, a 157% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $189,475 |
|---|---|
| Option Awards | $1,700,291 |
| Salary | $421,056 |
| Other | $18,650 |
| Total | $2,329,472 |
Guse received $1.7M in option awards, accounting for 73% of the total pay in 2019.
Guse also received $189.5K in non-equity incentive plan, $421.1K in salary and $18.7K in other compensation.
Rankings
In 2019, Kyle Guse's compensation ranked 5,179th out of 13,971 executives tracked by ExecPay. In other words, Guse earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,179 out of 13,971 | 63rd |
Division Manufacturing | 1,926 out of 5,695 | 66th |
Major group Chemicals And Allied Products | 676 out of 2,194 | 69th |
Industry group Drugs | 567 out of 1,880 | 70th |
Industry Pharmaceutical Preparations | 424 out of 1,392 | 70th |
Source: SEC filing on April 13, 2020.
Guse's colleagues
We found one more compensation record of an executive who worked with Kyle Guse at Atossa Genetics in 2019.
2019
Steven Quay
Atossa Genetics
Chief Executive Officer
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019